Methodological shortcomings.
作者信息
Hoffmann Falk, Schink Tania
出版信息
Dtsch Arztebl Int. 2014 Oct 3;111(40):680-1. doi: 10.3238/arztebl.2014.0680b.
Abstract
摘要
相似文献
1
Methodological shortcomings.
Dtsch Arztebl Int. 2014 Oct 3;111(40):680-1. doi: 10.3238/arztebl.2014.0680b.
2
In reply.
Dtsch Arztebl Int. 2014 Oct 3;111(40):681. doi: 10.3238/arztebl.2014.0681.
3
Cross-sector case management.
Dtsch Arztebl Int. 2014 Oct 3;111(40):680. doi: 10.3238/arztebl.2014.0680a.
4
Case management program for patients with chronic heart failure: effectiveness in terms of mortality, hospital admissions and costs.
Dtsch Arztebl Int. 2014 Apr 11;111(15):264-70. doi: 10.3238/arztebl.2014.0264.
5
Containing the Cost of Heart Failure Management: A Focus on Reducing Readmissions.
Card Electrophysiol Clin. 2015 Dec;7(4):577-84. doi: 10.1016/j.ccep.2015.08.002. Epub 2015 Sep 14.
6
Acute heart failure syndromes.
J Am Coll Cardiol. 2009 Feb 17;53(7):557-573. doi: 10.1016/j.jacc.2008.10.041.
7
[Patients with heart failure in the last year of their life: the primary care perspective].
G Ital Cardiol (Rome). 2014 Oct;15(10):569-76. doi: 10.1714/1672.18310.
8
Is an Admission for Decompensated Heart Failure Inevitable?
Prog Cardiovasc Dis. 2017 Sep-Oct;60(2):171-177. doi: 10.1016/j.pcad.2017.07.003. Epub 2017 Jul 18.
9
We are all in this "readmission" mission together.
Prof Case Manag. 2010 Jul-Aug;15(4):173-6. doi: 10.1097/NCM.0b013e3181eb6a96.
10
Disease management program for the elderly with heart failure.
J Cardiovasc Med (Hagerstown). 2007 May;8(5):318-9. doi: 10.2459/JCM.0b013e32813e41c1.
本文引用的文献
1
Case management program for patients with chronic heart failure: effectiveness in terms of mortality, hospital admissions and costs.
Dtsch Arztebl Int. 2014 Apr 11;111(15):264-70. doi: 10.3238/arztebl.2014.0264.
2
Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part III.
Value Health. 2009 Nov-Dec;12(8):1062-73. doi: 10.1111/j.1524-4733.2009.00602.x. Epub 2009 Sep 29.
3
Immeasurable time bias in observational studies of drug effects on mortality.
Am J Epidemiol. 2008 Aug 1;168(3):329-35. doi: 10.1093/aje/kwn135. Epub 2008 May 30.
Zotero 插件